Drug Trials, Pharmacokinetics and Regulations

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Trials

Pharmacokinetics

Regulations

What are the top disease areas for clinical drug trials?

Drug Discovery World

FEBRUARY 20, 2023

The approval was based on results from the PROpel Phase III trial, however, the drug was rejected by UK regulator NICE because it requires expensive genetic testing. An ongoing Phase I clinical trial will assess the safety and pharmacokinetics of AVA6000, which has potential in a range of cancer types.

Trials

Trials Drug Trials Disease Clinical Trials

Advanced 3D cell-based technologies

Drug Target Review

SEPTEMBER 19, 2023

This major shift to the orthodox tradition of using animal experiments in drug testing dates back the Aristotle’s time and cemented 80 years ago with initial federal mandate of drug safety regulation of 1938. Nature Cancer. 2022;3(4):418-36. Passini E, Britton OJ, Lu HR, Rohrbacher J, Hermans AN, Gallacher DJ, et al.

Animal Testing

Animal Testing Clinical Trials Pharmaceutical Companies FDA

Drug Discovery Digest

What are the top disease areas for clinical drug trials?

Advanced 3D cell-based technologies

Stay Connected